Bausch Health Companies Inc. (BHC)Healthcare | Drug Manufacturers - Specialty & Generic | Laval, Canada | NYSE
6.30 USD
-0.01
(-0.158%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
After hours: 6.19 -0.11 (-0.110%) ⇩ (Oct. 16, 2026, 6:54 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 10:47 a.m. EDT
The investment case for Bausch Health is fundamentally broken. The company is posting losses, trading at a negative book value, and has suffered a catastrophic 74% decline over the last nine years. While recent headlines celebrate a temporary earnings beat, the underlying business quality has eroded, evidenced by the market's relentless punishment over nearly a decade. The options market confirms this pessimism, with traders aggressively buying deep out-of-the-money puts, betting on a further collapse rather than a recovery. With no dividend to provide income and a balance sheet weighed down by debt, there is no margin of safety here. The recent price bounce is likely a dead cat bounce in a much larger downtrend, making this a dangerous hold for any investor seeking capital preservation or growth. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.062590 |
| AutoARIMA | 0.062591 |
| MSTL | 0.063186 |
| AutoTheta | 0.113156 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 1.80 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.163 |
| Excess Kurtosis | -1.21 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2010-11-09 |
| Last Dividend Date | 2010-11-09 |
| Revenue per Share | 29.12 |
| Market Cap | 2,356,140,544 |
| Forward P/E | 1.47 |
| Beta | 0.37 |
| Profit Margins | -10.12% |
| Website | https://www.bauschhealth.com |
As of Oct. 10, 2026, 10:47 a.m. EDT: Speculators are overwhelmingly positioned for downside protection, with massive open interest in deep out-of-the-money puts relative to calls. The distribution of put volume is heavily skewed toward strikes significantly below the current price, indicating a consensus expectation of a sharp decline rather than a modest correction.
| Date | Dividend | Yield % |
|---|---|---|
| 2010-11-10 | 1.000 | 3.901678 |
| 2010-08-30 | 0.095 | 0.419056 |
| 2010-05-28 | 0.095 | 0.632911 |
| 2010-03-04 | 0.090 | 0.584036 |
| 2009-11-30 | 0.090 | 0.623701 |
| 2009-08-28 | 0.090 | 0.704777 |
| 2009-05-13 | 0.090 | 0.827206 |
| 2009-03-06 | 0.375 | 3.475440 |
| 2008-12-19 | 0.375 | 4.162042 |
| 2008-08-21 | 0.375 | 3.720238 |
| 2008-05-20 | 0.375 | 3.078818 |
| 2008-03-25 | 0.375 | 3.446691 |
| 2007-11-16 | 0.375 | 2.238806 |
| 2007-08-16 | 0.375 | 2.241482 |
| 2007-05-18 | 0.375 | 1.528740 |
| 2007-03-22 | 0.375 | 1.732902 |
| 2007-01-08 | 0.500 | 2.428363 |
| 2006-11-20 | 0.125 | 0.728014 |
| 2006-08-16 | 0.125 | 0.787154 |
| 2006-05-19 | 0.125 | 0.494658 |
| 2006-04-05 | 0.125 | 0.500000 |
| 2005-11-28 | 0.500 | 2.174859 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.0015847683 |
| Address1 | 2,150 St. Elzéar Blvd. West |
| All Time High | 263.81 |
| All Time Low | 0.354167 |
| Ask | 6.45 |
| Ask Size | 3,200 |
| Audit Risk | 6 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 1,917,970 |
| Average Daily Volume3 Month | 3,270,543 |
| Average Volume | 3,270,543 |
| Average Volume10Days | 1,917,970 |
| Beta | 0.371 |
| Bid | 6.16 |
| Bid Size | 7,400 |
| Board Risk | 1 |
| Book Value | -4.737 |
| City | Laval |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 3 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.3 |
| Current Ratio | 1.435 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 6.385 |
| Day Low | 6.2 |
| Display Name | Bausch Health |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,217,600 |
| Earnings Call Timestamp Start | 1,793,217,600 |
| Earnings Growth | 0.704 |
| Earnings Quarterly Growth | 0.743 |
| Earnings Timestamp | 1,793,217,600 |
| Earnings Timestamp End | 1,793,217,600 |
| Earnings Timestamp Start | 1,793,217,600 |
| Ebitda | 3,908,000,000 |
| Ebitda Margins | 0.36008 |
| Enterprise To Ebitda | 5.701 |
| Enterprise To Revenue | 2.053 |
| Enterprise Value | 22,279,141,376 |
| Eps Current Year | 4.5205 |
| Eps Forward | 4.29267 |
| Eps Trailing Twelve Months | -2.95 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,289,347,200 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.1618 |
| Fifty Day Average Change | 0.13820028 |
| Fifty Day Average Change Percent | 0.022428557 |
| Fifty Two Week Change Percent | -0.15847683 |
| Fifty Two Week High | 8.0 |
| Fifty Two Week High Change | -1.6999998 |
| Fifty Two Week High Change Percent | -0.21249998 |
| Fifty Two Week Low | 4.33 |
| Fifty Two Week Low Change | 1.9700003 |
| Fifty Two Week Low Change Percent | 0.45496544 |
| Fifty Two Week Range | 4.33 - 8.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 764,951,400,000 |
| Five Year Avg Dividend Yield | 1.3 |
| Float Shares | 260,570,444 |
| Forward Eps | 4.29267 |
| Forward P E | 1.4676182 |
| Free Cashflow | 1,433,624,960 |
| Full Exchange Name | NYSE |
| Full Time Employees | 20,300 |
| Fullday Change | -0.119999886 |
| Fullday Change Percent | -1.9017415 |
| Fullday Price | 6.3 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.71823 |
| Gross Profits | 7,794,999,808 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11123 |
| Held Percent Institutions | 0.65111 |
| Implied Shares Outstanding | 373,990,561 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,289,347,200 |
| Last Dividend Value | 1.0 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 971,654,400 |
| Last Split Factor | 2:1 |
| Long Business Summary | Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. |
| Long Name | Bausch Health Companies Inc. |
| Market | us_market |
| Market Cap | 2,356,140,544 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_345779 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -1,098,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,137,534,049 |
| Number Of Analyst Opinions | 5 |
| Open | 6.35 |
| Operating Cashflow | 1,800,000,000 |
| Operating Margins | 0.27174 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.01 |
| Phone | 514 744 6792 |
| Post Market Change | -0.11000013 |
| Post Market Change Percent | -1.7460338 |
| Post Market Price | 6.19 |
| Post Market Time | 1,792,191,274 |
| Previous Close | 6.31 |
| Price Eps Current Year | 1.3936511 |
| Price Hint | 2 |
| Price To Book | -1.3299557 |
| Price To Sales Trailing12 Months | 0.21709578 |
| Profit Margins | -0.101169996 |
| Quick Ratio | 0.9 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | -0.00999975 |
| Regular Market Change Percent | -0.158475 |
| Regular Market Day High | 6.385 |
| Regular Market Day Low | 6.2 |
| Regular Market Day Range | 6.2 - 6.385 |
| Regular Market Open | 6.35 |
| Regular Market Previous Close | 6.31 |
| Regular Market Price | 6.3 |
| Regular Market Time | 1,792,180,802 |
| Regular Market Volume | 2,164,374 |
| Return On Assets | 0.065689996 |
| Revenue Growth | 0.127 |
| Revenue Per Share | 29.12 |
| Sand P52 Week Change | 0.13723719 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 373,990,561 |
| Shares Percent Shares Out | 0.0225 |
| Shares Short | 8,404,206 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 8,219,742 |
| Short Name | Bausch Health Companies Inc. |
| Short Percent Of Float | 0.028099999 |
| Short Ratio | 3.71 |
| Source Interval | 15 |
| State | QC |
| Symbol | BHC |
| Target High Price | 9.0 |
| Target Low Price | 6.5 |
| Target Mean Price | 7.5 |
| Target Median Price | 7.0 |
| Total Cash | 1,824,999,936 |
| Total Cash Per Share | 4.88 |
| Total Debt | 20,778,999,808 |
| Total Revenue | 10,853,000,192 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.95 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.7293 |
| Two Hundred Day Average Change | 0.57070017 |
| Two Hundred Day Average Change Percent | 0.0996108 |
| Type Disp | Equity |
| Volume | 2,164,374 |
| Website | https://www.bauschhealth.com |
| Zip | H7L 4A8 |